ALT Stock Analysis: Buy, Sell, or Hold?
ALT - Altimmune, Inc. Common Stock
$2.77
-0.07 (-2.46%)
▼
5d:
-3.48%
30d:
-6.1%
90d:
-4.15%
BUY
HIGH Confidence
Analysis Updated: Jul 24, 2026 12:00 AM ET
Earnings: Aug 11, 2026
15d
Get Alerted When ALT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ALT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: ALT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: ALT is currently trading at $2.77, which is considered slightly low relative to its 30-day fair value range of $2.76 to $3.06.
Technical Outlook: Technically, ALT is in a strong downtrend. The price is currently testing key support at $2.75. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.45 (+457.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ALT is in a strong downtrend. The price is currently testing key support at $2.75. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.45 (+457.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.76 -
$3.06
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 457.8% below Wall St target ($15.45)
Trading Range Analysis
30-Day Trading Range
$2.76 -
$3.06
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.75
Resistance Level
$3.02
Current Trend
Strong Downtrend
Technical data as of
Jul 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.23
Wall Street Target
$15.45
(+457.8%)
Revenue Growth (YoY)
420.0%
Share & Embed Analysis
Last updated: July 26, 2026 4:42 AM ET
Data refreshes hourly during market hours. Next update: 5:42 AM
Data refreshes hourly during market hours. Next update: 5:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALT showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Gregory L Weaver
BUY
5000 shares
2026-03-06
Jerome Benedict Durso
BUY
20000 shares
2026-03-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$86 | 59 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 47 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$23 | 51 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 56 HOLD |
